Back to the Top 100
Distalmotion logo

Rank 87MedTech & Devices

Distalmotion

Manufactures the Dexter robotic surgery system, combining laparoscopy with robotic precision in a hybrid approach.

Visit website
Signal Score
81.2
Total raised
$240M
Stage
Series D+
Founded
2012
Headquarters
Lausanne, Switzerland
Region
Europe

Their signal

Succeeds in the European market by offering a hybrid model that lets surgeons easily switch between manual laparoscopy and robotic steps, minimizing operating room disruption.

Signal Score 81.2editorial estimate, see how it is built
Capital (25% weight)86

Total raised, quality of investors and recency of the last round.

Growth (25% weight)80

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)82

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)83

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)72

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in MedTech & Devices

ShareLink copied

Did we miss something?

Change, add or remove details on this company. Our desk reviews every request.

Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.